Neoadjuvant Phase II Studies of Modified Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Cancer

被引：2
|
作者：
Adesunloye, Bamidele A. [1 ]
机构：
[1] Indiana Univ Sch Med, Lafayette, IN 46202 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 36期
关键词：
CHEMOTHERAPY; MULTICENTER; GEMCITABINE;
D O I：
10.1200/JCO.2014.57.9318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4170 / U405
页数：2
相关论文
共 50 条
  • [41] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Apolo, Andrea Borghese
    Regazzi, Ashley Marie
    Garcia-Grossman, Ilana Rebecca
    Pendse, Deepa
    Ostrovnaya, Irina
    Chou, Joanne F.
    Bochner, Bernard
    Dalbagni, Guido
    Herr, Harry W.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] A phase II clinical trial of toripalimab combined with cisplatin plus gemcitabine chemotherapy as neoadjuvant treatment for muscle-invasive bladder cancer
    Yang, Rong
    Li, Tianhang
    Zhang, Shun
    Zhang, Shiwei
    Guo, Hongqian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)
    Xu, Abai
    Xu, Peng
    Chen, Chunxiao
    Liu, Zhe
    Jiang, Ning
    Bi, Enguang
    Cao, Manming
    Chen, BinShen
    Liu, Chunxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.
    Gupta, Shilpa
    Agarwal, Neeraj
    Konety, Badrinath R.
    Weight, Christopher J.
    Thyagarajan, Bharat
    Murugan, Paari J.
    Koopmeiners, Joseph S.
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [45] Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer - Editorial comment
    Williams, RD
    JOURNAL OF UROLOGY, 2005, 174 (01): : 84 - 85
  • [46] Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy in Bladder Cancer: Ready for Prime Time?
    Pouessel, Damien
    Gauthier, Helene
    Serrate, Camille
    Pfister, Christian
    Culine, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4168 - U401
  • [47] Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
    Pfister, Christian
    Gravis, Gwenaelle
    Flechon, Aude
    Chevreau, Christine
    Mahammedi, Hakim
    Laguerre, Brigitte
    Guillot, Aline
    Joly, Florence
    Soulie, Michel
    Allory, Yves
    Harter, Valentin
    Culine, Stephane
    LANCET ONCOLOGY, 2024, 25 (02): : 255 - 264
  • [48] Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
    Pouessel, Damien
    Culine, Stephane
    Mongiat-Artus, Pierre
    EUROPEAN UROLOGY, 2011, 60 (04) : 870 - 871
  • [49] Neoadjuvant chemotherapy with gemcitabine and cisplatin for muscle-invasive bladder cancer: multicenter retrospective study
    Okabe, Ko
    Shindo, Tetsuya
    Maehana, Takeshi
    Nishiyama, Naotaka
    Hashimoto, Kohei
    Itoh, Naoki
    Takahashi, Atsushi
    Taguchi, Keisuke
    Tachiki, Hitoshi
    Tanaka, Toshiaki
    Masumori, Naoya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (10) : 934 - 941
  • [50] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Xing, N.
    Han, S.
    Jiang, J.
    Xu, W.
    Shi, B.
    Ping, H.
    Ji, Z.
    Ma, Q.
    Wang, H.
    Chen, S.
    Wang, W.
    Fan, X.
    Zhou, Q.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
12345